Disclosures for "Optimization of Neuromodulation Stimulation-advance Practice Providers (APPs) Led Quality Improvement Project (QI)"
-
Mrs. Wodajo has nothing to disclose.
-
Mrs. Mathew has nothing to disclose.
-
Ms. Hardeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Ms. Hardeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.